Up-regulation of the WNT-family ligand WNT1 in prostate cancer cells and a decrease in the serum of the WNT antagonist dikkopf-1 (DKK1) expression has been reported in patients with advanced metastatic prostate carcinoma and is associated with osteoblastic lesions [12]. The gene discussed is DKK1; the disease is prostate carcinoma.